DUBLIN–(BUSINESS WIRE)– The « Genome-Based Drug Industry Forecasts – China Focus » report has been added to ResearchAndMarkets.com’s offering.
This study focuses on China’s Genome-Based Drug industry forecasts. In the two past decades, the industry has been growing at a fast pace.
The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services.
The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades.
Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study focuses on industry trends and forecasts with historical data (2010, 2015 and 2020) and long-term forecasts through 2025 and 2030 are presented.
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS
For more information about this report visit https://www.researchandmarkets.com/r/umjw0p
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Source: Research and Markets